Andrea Miller v. HHS - Tdap, Guillain-Barré syndrome (2022)

Filed 2019-01-24Decided 2022-02-18Vaccine Tdap
compensated$56,972

Case summary [AI summaries can sometimes make mistakes]

Andrea Miller filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging that the Tdap vaccine she received on January 24, 2016, caused her to suffer from Guillain-Barré syndrome (GBS) and experience residual effects for more than six months. Respondent, the Secretary of Health and Human Services, denied that the Tdap immunization caused Petitioner's alleged GBS and/or any other injury.

Despite this denial, the parties filed a joint stipulation for award, agreeing that Petitioner should receive compensation. The stipulation was approved by the Special Master.

Andrea Miller was awarded a total of $56,972.03. This amount included $6,972.03 to satisfy a State of Florida Medicaid lien and a lump sum of $50,000.00 for all remaining compensation for damages.

The parties agreed to expedite the entry of judgment by renouncing the right to seek review.

Source PDFs 2 total · 1 downloaded